Michel G. Bergeron

Affiliation : Université Laval
Organization : Centre hospitalier universitaire de Québec (CHUQ)
E-mail : michel.g.bergeron@crchul.ulaval.ca
Web site

About Michel G. Bergeron

Michel G. Bergeron is professor of microbiology and infectious diseases as well as the Founder and Director of the Centre de recherche en infectiologie of Université Laval, one of the largest infectious diseases research centres in North America. A world renowned researcher, he is the author of more than 400 publications. Dr. Bergeron and his team were the first to develop innovative DNA-based tests which allow the specific identification of microbes and their antibiotic resistance genes in less than one hour instead of the usual 2 to 3 days. Several FDA approved real-time PCR tests to diagnose and better control hospital-acquired infections due to methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and Clostridium difficile are derived from his research laboratory. These “personalized medicine” tests, insuring real-time diagnostics and treatment, are saving many lives while reducing healthcare costs. In 1995, to transform discoveries into products, he created Infectio Diagnostic Inc. which was acquired by Becton Dickinson (BD) in 2006. These high clinical value tests are fabricated in Québec City (350 employees) and commercialized throughout the world by BD. Dr. Bergeron is now developing, with his transdisciplinary team, a simple “lab-on-a-chip” device on a compact disc platform that reads DNA rapidly and which will allow the detection of infections at point-of-care.

Ongoing competitions